Prior anticoagulation in patients with ischemic stroke and atrial fibrillation
Sign Up to like & getrecommendations! Published in 2021 at "Annals of Neurology"
DOI: 10.1002/ana.26183
Abstract: To the Editor: Meinel and colleagues reported the effect of prior anticoagulation with vitamin K antagonists or direct oral anticoagulants (DOACs) on subsequent stroke severity, utilization of intravenous thrombolysis (IVT), safety of IVT, and 3-month… read more here.
Keywords: ischemic stroke; safety; patients ischemic; stroke ... See more keywords
TIMI‐AF score and cardiovascular events in vitamin K antagonists‐naïve outpatients with atrial fibrillation
Sign Up to like & getrecommendations! Published in 2018 at "Clinical Cardiology"
DOI: 10.1002/clc.23035
Abstract: The TIMI‐AF score predicts poor outcomes in patients with atrial fibrillation (AF) and guides selection of anticoagulant therapy by identifying clinical benefit of direct oral anticoagulants (DOACs) or vitamin K antagonists (VKA). read more here.
Keywords: atrial fibrillation; vitamin antagonists; timi score;
Systematic review of efficacy of direct oral anticoagulants and vitamin K antagonists in left ventricular thrombus
Sign Up to like & getrecommendations! Published in 2022 at "ESC Heart Failure"
DOI: 10.1002/ehf2.14084
Abstract: Left ventricular thrombus (LVT) increases the risk of thrombotic events and mortality. Vitamin K antagonists (VKAs) used to treat LVT have several known risks, as a result of which direct oral anticoagulant (DOAC) use has… read more here.
Keywords: ventricular thrombus; vitamin antagonists; efficacy; direct oral ... See more keywords
[Vitamin K antagonists : Is their prescription really "medical malpractice" today?]
Sign Up to like & getrecommendations! Published in 2017 at "Der Internist"
DOI: 10.1007/s00108-016-0168-x
Abstract: Atrial fibrillation and venous thromboembolisms are frequent cardiovascular diseases. Until a few years ago only vitamin K antagonists (VKA) were available for oral anticoagulation as primary and secondary prevention of thrombembolic events. Currently, the non-vitamin… read more here.
Keywords: antagonists prescription; today; medical malpractice; prescription really ... See more keywords
Vitamin K antagonists for stroke prevention in hemodialysis patients with atrial fibrillation: A systematic review and meta-analysis.
Sign Up to like & getrecommendations! Published in 2017 at "American Heart Journal"
DOI: 10.1016/j.ahj.2016.09.016
Abstract: Background The use of vitamin K antagonists (VKAs) in hemodialysis patients with atrial fibrillation (AF) is controversial. No randomized trials are available and observational studies have yielded conflicting results, engendering a large clinical practice variability… read more here.
Keywords: hemodialysis; risk; hemodialysis patients; vitamin antagonists ... See more keywords
Time to therapeutic range (TtTR), anticoagulation control, and cardiovascular events in vitamin K antagonists–naive patients with atrial fibrillation
Sign Up to like & getrecommendations! Published in 2018 at "American Heart Journal"
DOI: 10.1016/j.ahj.2018.03.004
Abstract: Background: Vitamin K antagonists (VKAs) reduce cardiovascular events (CVEs) in atrial fibrillation (AF) when a time in therapeutic range (TiTR) >70% is achieved. Factors affecting the time to achieve the TR (TtTR) are unknown. Methods:… read more here.
Keywords: titr; atrial fibrillation; range; time ... See more keywords
Direct oral anticoagulants versus vitamin K antagonists in antiphospholipid syndrome: A meta-analysis.
Sign Up to like & getrecommendations! Published in 2020 at "European journal of internal medicine"
DOI: 10.1016/j.ejim.2020.05.012
Abstract: BACKGROUND Anticoagulant treatment is recommended in patients with thrombosis and antiphospholipid syndrome (APS). Conflicting results have been reported on the role of direct oral anticoagulants (DOACs) in these patients. We performed a meta-analysis of randomized… read more here.
Keywords: antiphospholipid syndrome; oral anticoagulants; direct oral; vitamin antagonists ... See more keywords
Comparison of Anticoagulant Therapy for Atrial Fibrillation - Novel Oral Anticoagulants Versus Vitamin K Antagonists.
Sign Up to like & getrecommendations! Published in 2018 at "Progress in cardiovascular diseases"
DOI: 10.1016/j.pcad.2018.01.005
Abstract: In patients with non-valvular atrial fibrillation (NVAF), oral anticoagulation is important for prevention of stroke and systemic embolism (SE). While Vitamin K antagonists (VKAs) have historically been the standard of care, these medications are limited… read more here.
Keywords: atrial fibrillation; oral anticoagulants; comparison anticoagulant; novel oral ... See more keywords
Direct oral anticoagulants versus vitamin K antagonists in real-world patients with nonvalvular atrial fibrillation. The FANTASIIA study.
Sign Up to like & getrecommendations! Published in 2019 at "Revista espanola de cardiologia"
DOI: 10.1016/j.rec.2019.02.021
Abstract: INTRODUCTION AND OBJECTIVES To compare the long-term results of direct oral anticoagulants (DOAC) vs vitamin K antagonists (VKA) in real-world-patients with nonvalvular atrial fibrillation (NVAF) in a nationwide, prospective study. METHODS The FANTASIIA registry prospectively… read more here.
Keywords: world patients; real world; death; oral anticoagulants ... See more keywords
Therapeutic quality control in a regional thrombosis center: The effect of changing the target intensity of anticoagulation with vitamin K antagonists.
Sign Up to like & getrecommendations! Published in 2021 at "Thrombosis research"
DOI: 10.1016/j.thromres.2021.04.024
Abstract: BACKGROUND The target ranges (TR) for anticoagulation with vitamin K antagonists (VKA) in the Netherlands were changed in 2016 from INR 2.0-3.5 ('low intensity') and INR 2.5-4.0 ('high intensity') to INR 2.0-3.0 and INR 2.5-3.5,… read more here.
Keywords: inr; target; intensity; anticoagulation vitamin ... See more keywords
Uso de anticoagulantes orales en situaciones clínicas complejas con fibrilación auricular
Sign Up to like & getrecommendations! Published in 2018 at "Medicina Clinica"
DOI: 10.1016/s0025-7753(18)30666-3
Abstract: The present article provides an update on anticoagulant treatment in patients with atrial fibrillation in distinct clinical scenarios requiring particular considerations, such as ischaemic heart disease, electrical cardioversion, pulmonary vein ablation, the presence of valvular… read more here.
Keywords: atrial fibrillation; fibrillation; disease; direct acting ... See more keywords